Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Pamplona
Clinical trial register · Spain

Clinical Trials in Pamplona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 26 Madrid 23 Pamplona 15 Badalona 12 Seville 11
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona26 Madrid23 Pamplona15 Badalona12 Seville11
All 49 locations
Target enrolment
to

Trials with a site in Pamplona

15 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Regeneron Pharmaceuticals
Phase 2
120
Seville, Barcelona, A Coruña, Pamplona, Madrid, Zaragoza
2026-04-14
Recruiting
Regeneron Pharmaceuticals
Phase 1
90
Seville, Pamplona, Madrid, Málaga
2025-12-22
Recruiting
Regeneron Pharmaceuticals
Phase 3
2,000
Vitoria-Gasteiz, Marbella, Pamplona, Barcelona, Madrid, Valencia
2025-11-24
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Badalona, Santander, Las Palmas de Gran Canaria, Pamplona, Madrid, Seville, Valencia, Zaragoza
2024-11-18
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
220
Palma, Pamplona, Gijón, Barcelona, Valencia
2024-08-07
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Santiago de Compostela, Elche, Granada, Palma, Barcelona, Majadahonda, El Palmar, Pamplona
2024-07-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
216
Palma, Madrid, Pamplona, Valencia
2024-02-15
Active, closed
Regeneron Pharmaceuticals
Phase 2
40
Santiago de Compostela, Granada, Palma Mallorca, Badalona, Santander, Pozuelo de Alarcón, El Palmar, Pamplona
2024-01-30
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca
2023-12-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
36
Pamplona, Barcelona, Las Palmas de Gran Canaria, Madrid
2023-06-27
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Badalona, Manresa, Castellon, Madrid, Málaga, Pamplona, Valencia
2023-04-21
Recruiting
Regeneron Pharmaceuticals
Phase 1
317
Santiago de Compostela, Badalona, Santander, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Salamanca
2022-08-17
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Barcelona, Pamplona, Madrid, Salamanca
2019-01-23
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pamplona, Badalona, Barcelona, Madrid, Santiago de Compostela
2018-05-21
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/pamplona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Pamplona that also match the filters currently applied.

How many clinical trials are recruiting in Pamplona?

9 of the 15 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pamplona), 15 studies
PhaseStudiesRecruitingShare
Phase 1/25533.3%
Phase 25133.3%
Phase 33120%
Phase 12213.3%

Most active sponsors

Lead sponsors with the most studies (Pamplona)
Lead sponsorStudiesRecruiting
Regeneron Pharmaceuticals159
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.